Home/Filings/4/0001362118-21-000014
4//SEC Filing

Galluppi Stefan 4

Accession 0001362118-21-000014

CIK 0000948320other

Filed

May 20, 8:00 PM ET

Accepted

May 21, 11:54 AM ET

Size

5.7 KB

Accession

0001362118-21-000014

Insider Transaction Report

Form 4
Period: 2021-05-19
Galluppi Stefan
Chief Innovation Officer
Transactions
  • Purchase

    Common Stock, par value $0.01

    2021-05-19$10.40/sh+3,796$39,4783,796 total
Holdings
  • Common Stock, par value $0.01

    (indirect: By LLC)
    1,649,800
Footnotes (1)
  • [F1]An audit of the reporting person's indirect holdings resulted in a slight adjustment in shares beneficially owned. The holdings reported on this Form 4 are the correct amount of indirectly held securities beneficially owned.

Issuer

LifeMD, Inc.

CIK 0000948320

Entity typeother

Related Parties

1
  • filerCIK 0001722649

Filing Metadata

Form type
4
Filed
May 20, 8:00 PM ET
Accepted
May 21, 11:54 AM ET
Size
5.7 KB